Patient-partnered Research: a Key to Investigating Fear of Cancer Recurrence in Patients With Surgically Treated Kidney Cancer (PP-RECURK)

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners/spouses by 1) establishing a panel consisting of patients with or without partners/spouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners/spouses. In phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer. In phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

⁃ Phase 1:

• Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse

• Partner/spouse to patients who fullfil the inclusion criteria

• Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)

• Time since surgery: 0-120 months

• Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish

• Patients/partners/spouses able to and willing to attend online project meetings or in person at Gødstrup Hospital.

⁃ Phase 2:

• Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse

• Partner/spouse to patients who fullfill the inclusion criteria

• Patients who have undergone surgery due to localized RCC (T1-T2-T3 tumor)

• Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish

• Able to receive digital communication from the hospital

• Informed consent must be signed before answering Fear of Cancer Recurrence questions

Locations
Other Locations
Denmark
Aalborg University Hospital
NOT_YET_RECRUITING
Aalborg
Aarhus University Hospital
RECRUITING
Aarhus
Gødstrup Hospital
NOT_YET_RECRUITING
Herning
Contact Information
Primary
Brigitta R Villumsen, PhD
brigvill@rm.dk
+45 20487820
Backup
Anne H Nielsen, PhD
annsve@rm.dk
+45 2015 8924
Time Frame
Start Date: 2025-09-30
Estimated Completion Date: 2027-01
Participants
Target number of participants: 105
Treatments
Panel members
6 patients with spouses/partners and 3 single patients. In total 15 subjects.
Pilot population
In total 90 subjects (patients with or without partners)
Related Therapeutic Areas
Sponsors
Leads: Brigitta Rasmussen Villumsen
Collaborators: Aalborg University Hospital, Aarhus University Hospital

This content was sourced from clinicaltrials.gov